Skip to main content

Advertisement

Table 4 Baseline characteristics

From: Design and baseline data in the BAriatic surgery SUbstitution and Nutrition study (BASUN): a 10-year prospective cohort study

 MT (n = 382)RYGB (n = 388)SG (n = 201)P
Female276 (72,3)301 (77,6)152 (75,6)0.206
Age (years)49.0 (18–78)43.5 (18–62)41 (18–63)< 0.0001
BMI (kg/m2)40.1 (31.6–90.4)41.8 (34.8–65.3)41.6 (35–63.7)< 0.0001
HbA1c (mmol/mol)36 (25.0–95.0)37 (26–118)36 (27–73)0.173
HDL (mmol/l)1.3 (0.6–2.6)1.2 (0.4–2.3)1.2 (0.7–2.0)0,003
LDL (mmol/l)3.1 (1.2–6.7)3.2 (0.8–6.2)3.3 (0.9–5.7)0.627
Glucose lowering treatment55 (14,4)55 (14,2)28 (13,9)0.990
Blood pressure lowering treatment135 (35,3)112 (28,9)58 (28,9)0.109
Lipid lowering treatment52 (13,6)51 (13,1)23 (11,4)0.768
Treatment for anxiety/depression85 (22,3)68 (17,5)52 (25,9)0.101
Treatment with antipsychotics13 (3,4)4 (1,0)6 (3,0)0.078
Pain medication80 (20,9)63 (16,2)38 (18,9)0.238
Hypothyroidism treatment49 (12,8)42 (10,8)26 (12,9)0.613
ADHD treatment8 (2,1)2 (0,5)2 (1)0.124
Iron supplements5 (1,3)3 (0,8)3 (1,5)0.685
B-vitamin supplements14 (3,7)9 (2,3)9 (4,5)0.313
D-vitamin supplements3 (0,8)7 (1,8)4 (2,0)0.347
Folic acid supplements6 (1,6)4 (1,0)6 (3,0)0.221
Calcium supplements6 (1,6)1 (0,3)0 (0)0.055
Protonpump inhibitor treatment50 (13,1)39 (10,1)30 (14,9)0.180
Education   0.082
 Elementary51 (13,4)42 (10,8)15 (7,5) 
 Secondary141 (36,9)199 (51,3)98 (48,8) 
 Tertiary127 (33,2)101 (26,0)69 (34,3) 
Smoking23 (6,0)24 (6,2)13 (6,5)0.884
Married/cohabitation206 (53,9)242 (62,4)121 (60,2)0.955
  1. Data are n (%) or median (range)
  2. MT Medical treatment, GBP Roux-en-Y gastric bypass, SG Sleeve gastrectomy, BMI Body mass index, HDL High-density lipoprotein, LDL Low-density lipoprotein